Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Prostatic Neoplasms 5Urinary Bladder Neoplasms 2Male Urogenital Diseases 2Smoking Cessation 1Pancreatic Neoplasms 1Pain, Postoperative 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lung Neoplasms 1Lung Cancer Prevention 1Leiomyoma 1Inflammatory Bowel Diseases 1Duodenal Neoplasms 1Diverticulitis 1Colonic Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Carboplatin 195Cisplatin 117Paclitaxel 107Pemetrexed 106Docetaxel 96Gemcitabine 89Radiotherapy 83Erlotinib Hydrochloride 58Bevacizumab 55Etoposide 49durvalumab 39pembrolizumab 38Nivolumab 31Specimen Handling 30Magnetic Resonance Spectroscopy 30Irinotecan 27Radiosurgery 26osimertinib 24Gefitinib 24Drug Therapy 23Vinorelbine 22atezolizumab 20Topotecan 20Radiation 16Cetuximab 16Taxes 15Surgical Procedures, Operative 14Neoadjuvant Therapy 13Filgrastim 13Chemotherapy, Adjuvant 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lung Neoplasms × Tea × Clear all
NCT00363805 2013-11-28

Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary Disease

University of Arizona

Phase 2 Completed
178 enrolled 10 charts
Thoracic

Lung Neoplasms, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡